Abstract
BackgroundBlockade of JAK, preferably JAK1, by upadacitinib is a feasible approach to achieve erosion repair as it 1) is approved for the treatment of rheumatoid arthritis (RA), 2) effectively controls...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have